𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Allergic disease after pediatric liver transplantation with systemic tacrolimus and cyclosporine a therapy

✍ Scribed by C Arikan; M Kilic; Y Tokat; S Aydogdu


Book ID
116929383
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
58 KB
Volume
35
Category
Article
ISSN
0041-1345

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Cyclosporine A withdrawal during follow-
✍ Rene Scheenstra; Maarten L.J. Torringa; Herman J. Waalkens; Erik H. Middelveld; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 128 KB

It is unclear whether cyclosporine A (CsA) can be withdrawn safely during follow-up after pediatric liver transplantation. In our transplant program we have been using a strict protocol to withdraw CsA. The aim of this study was to retrospectively assess the effects of CsA withdrawal after pediatric

Late hypertension after liver transplant
✍ Canzanello, Vincent J. ;Textor, Stephen C. ;Taler, Sandra J. ;Schwartz, Lora L. πŸ“‚ Article πŸ“… 1998 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 198 KB

Hypertension frequently develops early after liver transplantation when cyclosporine-based immunosuppression is used. However, initial experience with tacrolimus has suggested that its use leads to a lower early incidence of hypertension. In this study, the blood pressure status of patients treated

Tacrolimus and cyclosporin doses and blo
✍ Ye H. Oo; Tracey Dudley; Peter Nightingale; Geoffrey Haydon; David Mutimer πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 307 KB

Hepatitis C virus (HCV)-induced cirrhosis is the most common indication for liver transplantation (LT). However, graft reinfection is nearly universal. The choice of immunosuppression, including the calcineurin inhibitor (CNI), may have some effect on severity of recurrence and graft survival. In ad